Peritoneal Dialysis International · 1995 · 17 citations · 39 references
MedicinePharmacologyPharmacotherapyBiopharmaceuticsClinical PharmacologyDialysisAmino Acid TherapyDialysis PharmacotherapyPeritoneal DialysisAmino AcidsIntraperitoneal AdministrationNutritional Status EvaluationPeritoneal Dialysis Care
In regard to the question posed in the title of this review, the answer is mixed. IPN is possible today but only on a limited basis and at high cost with uncertain benefit. A 1.1% amino acid dialysis solution for IPAA therapy is available in several European countries but has not yet been approved for use in the United States. When it becomes more widely available, IPAA should become an important tool, along with other types of therapy, for use in the maintenance of good nutritional status in PD patients.
39
Modern Nutrition in Health and Disease.
Annals of Internal Medicine · 1988 · 3.4K citations
Advances in peritoneal dialysis.
R.T. Krediet · PubMed · 2007 · 577 citations
Medicine, Nephrology, Dialysis +16
Protein losses during peritoneal dialysis
Michael J. Blumenkrantz, Gerhard M. Gahl, Joel D. Kopple et al. · Kidney International · 1981 · 379 citations
Medicine, Nephrology, Nutrition +12